Highlights of the first century of human tumour virology
The latest results from the 2023 TEXAIS trial indicated that the use of exenatide (5 g, twice daily injections for 5 days) did not significantly reduce neurological damage within 7 days in patients with acute ischemic stroke (trial registration numbers: ACTRN12617000409370 and NCT03287076)
Januvia is a DDP-4 inhibitor and is used to treat type 2 diabetes in adults
Consult the cryo-EM structural data for mechanistic context on receptor binding geometry [9]
22 The comments made on these studies reflect the need for greater dialogue in a broader sense of the challenges of using large databases for addressing ophthalmic, and DR-specific, questions
For patients with obesity and comorbidities (type 2 diabetes, hypertension, sleep apnea), referral to obesity medicine specialists or registered dietitians is appropriate for comprehensive management